> top > projects > sentences > docs > PubMed:10336987 > annotations
sentences Home  

PubMed:10336987 JSONTXT 52 Projects

Annnotations TAB TSV DIC JSON TextAE Lectin_function IAV-Glycan

Id Subject Object Predicate Lexical cue
TextSentencer_T1 0-142 Sentence denotes Glycosylation of the overlapping sequons in yeast external invertase: effect of amino acid variation on site selectivity in vivo and in vitro.
T1 0-142 Sentence denotes Glycosylation of the overlapping sequons in yeast external invertase: effect of amino acid variation on site selectivity in vivo and in vitro.
T1 0-142 Sentence denotes Glycosylation of the overlapping sequons in yeast external invertase: effect of amino acid variation on site selectivity in vivo and in vitro.
TextSentencer_T2 143-293 Sentence denotes Yeast invertase contains 14 sequons, all of which are glycosylated to varying degrees except for sequon 5 which is marginally glycosylated, if at all.
T2 143-293 Sentence denotes Yeast invertase contains 14 sequons, all of which are glycosylated to varying degrees except for sequon 5 which is marginally glycosylated, if at all.
T2 143-293 Sentence denotes Yeast invertase contains 14 sequons, all of which are glycosylated to varying degrees except for sequon 5 which is marginally glycosylated, if at all.
TextSentencer_T3 294-403 Sentence denotes This sequon overlaps with sequon 4 in a sequence consisting of Asn92-Asn93-Thr94-Ser95(Reddy et al., 1988, J.
T3 294-403 Sentence denotes This sequon overlaps with sequon 4 in a sequence consisting of Asn92-Asn93-Thr94-Ser95(Reddy et al., 1988, J.
T3 294-433 Sentence denotes This sequon overlaps with sequon 4 in a sequence consisting of Asn92-Asn93-Thr94-Ser95(Reddy et al., 1988, J. Biol. Chem., 263, 6978-6985).
TextSentencer_T4 404-409 Sentence denotes Biol.
T4 404-409 Sentence denotes Biol.
TextSentencer_T5 410-433 Sentence denotes Chem., 263, 6978-6985).
T5 410-433 Sentence denotes Chem., 263, 6978-6985).
TextSentencer_T6 434-706 Sentence denotes To determine whether glycosylation at Asn93is sterically hindered by the oligosaccharide on Asn92, the latter amino acid was converted to a glutamine residue by site-directed mutagenesis of the SUC2 gene in a plasmid vector which was expressed in Saccharomyces cerevisiae.
T4 434-706 Sentence denotes To determine whether glycosylation at Asn93is sterically hindered by the oligosaccharide on Asn92, the latter amino acid was converted to a glutamine residue by site-directed mutagenesis of the SUC2 gene in a plasmid vector which was expressed in Saccharomyces cerevisiae.
T6 434-706 Sentence denotes To determine whether glycosylation at Asn93is sterically hindered by the oligosaccharide on Asn92, the latter amino acid was converted to a glutamine residue by site-directed mutagenesis of the SUC2 gene in a plasmid vector which was expressed in Saccharomyces cerevisiae.
TextSentencer_T7 707-974 Sentence denotes A glycopeptide encompassing sequons 3 through 6 was purified from a tryptic digest of the mutagenized invertase and sequenced by Edman degradation, which revealed that Asn93 of sequon 5 contained very little, if any, carbohydrate, despite the elimination of sequon 4.
T5 707-974 Sentence denotes A glycopeptide encompassing sequons 3 through 6 was purified from a tryptic digest of the mutagenized invertase and sequenced by Edman degradation, which revealed that Asn93 of sequon 5 contained very little, if any, carbohydrate, despite the elimination of sequon 4.
T7 707-974 Sentence denotes A glycopeptide encompassing sequons 3 through 6 was purified from a tryptic digest of the mutagenized invertase and sequenced by Edman degradation, which revealed that Asn93 of sequon 5 contained very little, if any, carbohydrate, despite the elimination of sequon 4.
TextSentencer_T8 975-1211 Sentence denotes When Ser and Thr were inverted to yield Asn-Asn-Ser-Thr carbohydrate was associated primarily with the second sequon, in agreement with numerous studies indicating that Asn-X-Thr is preferred to Asn-X-Ser as an oligosaccharide acceptor.
T6 975-1211 Sentence denotes When Ser and Thr were inverted to yield Asn-Asn-Ser-Thr carbohydrate was associated primarily with the second sequon, in agreement with numerous studies indicating that Asn-X-Thr is preferred to Asn-X-Ser as an oligosaccharide acceptor.
T8 975-1211 Sentence denotes When Ser and Thr were inverted to yield Asn-Asn-Ser-Thr carbohydrate was associated primarily with the second sequon, in agreement with numerous studies indicating that Asn-X-Thr is preferred to Asn-X-Ser as an oligosaccharide acceptor.
TextSentencer_T9 1212-1372 Sentence denotes However, when the invertase overlapping sequons were converted to Asn-Asn-Ser-Ser, both sequons were clearly glycosylated, with the latter sequon predominating.
T7 1212-1372 Sentence denotes However, when the invertase overlapping sequons were converted to Asn-Asn-Ser-Ser, both sequons were clearly glycosylated, with the latter sequon predominating.
T9 1212-1372 Sentence denotes However, when the invertase overlapping sequons were converted to Asn-Asn-Ser-Ser, both sequons were clearly glycosylated, with the latter sequon predominating.
TextSentencer_T10 1373-1492 Sentence denotes These findings rule out steric hindrance as a factor involved in preventing the glycosylation of sequon 5 in invertase.
T8 1373-1492 Sentence denotes These findings rule out steric hindrance as a factor involved in preventing the glycosylation of sequon 5 in invertase.
T10 1373-1492 Sentence denotes These findings rule out steric hindrance as a factor involved in preventing the glycosylation of sequon 5 in invertase.
TextSentencer_T11 1493-1656 Sentence denotes Comparable results were obtained using an in vitro system with sequon-containing tri- and tetrapeptides acceptors, in addition to larger oligosaccharide acceptors.
T9 1493-1656 Sentence denotes Comparable results were obtained using an in vitro system with sequon-containing tri- and tetrapeptides acceptors, in addition to larger oligosaccharide acceptors.
T11 1493-1656 Sentence denotes Comparable results were obtained using an in vitro system with sequon-containing tri- and tetrapeptides acceptors, in addition to larger oligosaccharide acceptors.